Munich Re: Seeing A Pressured Valuation For 2026-2027E

2025-04-29 13:24:58 ET

Summary

• Munich Re has outperformed expectations, but its current valuation is significantly inflated, making it risky for new investments despite solid fundamentals and strong performance.
• The company's focus on global specialty insurance and cyber insurance is promising, but the market's premium valuation is not justified by unique operational advantages.
• Risks include potential declines in P&C volumes, market volatility, and capital intensity in the ERGO segment, which could erode earnings.
• I recommend a "Hold" rating with a PT of €400/share, as the current valuation does not offer a sufficient margin of safety for new investments.

Dear readers/followers,

To say that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München aka Munich Re ( MURGY ) has beaten my expectations would be putting it lightly. I bought the company at what has now been shown to be an extremely cheap and pressured valuation. I rotated my holdings in the company at what I then believed to be a "peak" for the company, from which the company would proceed to drop. It didn't really drop from it, however, but kept rising....

Read the full article on Seeking Alpha

For further details see: